Spindle Biotech specializes in providing customized synthetic guide RNA arrays designed for high-throughput CRISPR experiments. Operating in the biotechnology sector, the company primarily serves research institutions, pharmaceutical companies, and biotech firms engaged in gene editing research. Spindle Biotech's core product is synthetic guide RNA, which offers a more reliable and precise alternative to plasmid-based approaches commonly used in CRISPR experiments. By focusing on synthetic RNA, the company addresses issues of precision, accuracy, and reproducibility that are often compromised with plasmid DNA due to differential expression and constant overexpression of Cas9 protein and guide RNA.

The business model of Spindle Biotech revolves around the production and sale of high-quality synthetic guide RNA at competitive prices. For instance, their custom 96-well plate RNA is priced at 69.00 CAD per guide RNA, which is among the lowest in the industry. The company ensures the highest quality through internal verification processes and offers a satisfaction guarantee to accommodate the variability in scientific research outcomes.

Spindle Biotech generates revenue through direct sales of its synthetic RNA products to its target clientele. The company also offers promotional pricing and customized solutions to meet the specific needs of different research projects, thereby fostering long-term relationships with its clients.

Keywords: synthetic RNA, CRISPR, gene editing, biotechnology, high-throughput, precision, accuracy, reproducibility, research institutions, pharmaceutical companies.